World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: Treatment of bipolar depression

Heinz Grunze, Siegfried Kasper, Guy Goodwin, Charles Bowden, David Baldwin, Rasmus Licht, Eduard Vieta, Hans Jürgen Möller

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Abstract

These practice guidelines for the biological, mainly pharmacological treatment of bipolar depression were developed by an international task force of the World Federation of Societies of Biological Psychiatry (WFSBP). Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of bipolar depression. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, and from recent proceedings of key conferences and various national and international treatment guidelines. Their scientific rigor was categorised into four levels of evidence (A-D). As these guidelines are intended for clinical use, the scientific evidence was not only graded, but also commented on by the experts of the task force to ensure practicability.

Original languageEnglish (US)
Pages (from-to)115-124
Number of pages10
JournalWorld Journal of Biological Psychiatry
Volume3
Issue number3
DOIs
StatePublished - 2002

Keywords

  • acute treatment
  • antidepressants
  • bipolar disorder
  • depression
  • electroconvulsive therapy
  • evidence-based guidelines
  • mood stabiliser
  • pharmacotherapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: Treatment of bipolar depression'. Together they form a unique fingerprint.

Cite this